Involvement of bone marrow-derived stromal cells in gastrointestinal cancer development and metastasis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 23, Issue SUPPL. 2, 2008, Pages

  Ishii, Shuji ^a   Tsuji, Shingo ^a   Tsujii, Masahiko ^a   Kanazawa, Yoshiyuki ^a   Nishida, Tsutomu ^a   Iijima, Hideki ^a   Yasumaru, Masakazu ^a   Irie, Takanobu ^a   Yamamoto, Katsumi ^a   Tsutsui, Shusaku ^a   Eguchi, Hiroshi ^a   Kawano, Sunao ^a   Hayashi, Norio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone marrow; Colon cancer; Metastasis; Mouse; Myofibroblast

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GREEN FLUORESCENT PROTEIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BONE MARROW; BONE MARROW TRANSPLANTATION; CARCINOGENESIS; COLON CANCER; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA CELL; TUMOR GROWTH;

EID: 57449122020     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05446.x     Document Type: Conference Paper

References (30)

1. Beacham DA, Cukierman E. Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression. Semin. Cancer Biol. 2005 15 : 329 41.
2. Yu P, Rowley DA, Fu YX et al. The role of stroma in immune recognition and destruction of well-established solid tumors. Curr. Opin. Immunol. 2006 18 : 226 31.
3. Gregoire M, Lieubeau B. The role of fibroblasts in tumor behavior. Cancer Metastasis Rev. 1995 14 : 339 50.
4. Petersen BE, Bowen WC, Patrene KD et al. Bone marrow as a potential source of hepatic oval cells. Science 1999 284 : 1168 70.
5. Aghi M, Chiocca EA. Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumors. Mol. Ther. 2005 12 : 994 1005.
6. Lyden D, Hattori K, Dias S et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 2001 7 : 1194 201.
7. Bamba S, Lee CY, Brittan M et al. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice. J. Pathol. 2006 209 : 265 73.
8. Okamoto R, Yajima T, Yamazaki M et al. Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat. Med. 2002 8 : 1011 7.
9. Komori M, Tsuji S, Tsujii M et al. Efficiency of bone marrow-derived cells in regeneration of the stomach after induction of ethanol-induced ulcers in rats. J. Gastroenterol. 2005 40 : 591 9.
10. Komori M, Tsuji S, Tsujii M et al. Involvement of bone marrow-derived cells in healing of experimental colitis in rats. Wound Repair Regen. 2005 13 : 109 18.
11. Terada N, Hamazaki T, Oka M et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002 416 : 542 5.
12. Rodic N, Rutenberg MS, Terada N. Cell fusion and reprogramming: resolving our transdifferences. Trends Mol. Med. 2004 10 : 93 6.
13. Okabe M, Ikawa M, Kominami K et al. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 1997 407 : 313 9.
14. Cameron RB, Spiess PJ, Rosenberg SA. Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action. J. Exp. Med. 1990 171 : 249 63.
15. Rosenberg SA, Spiess P, Lafreniere R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 1986 233 : 1318 21.
16. Matz MV, Fradkov AF, Labas YA et al. Fluorescent proteins from nonbioluminescent Anthozoa species. Nat. Biotechnol. 1999 17 : 969 73.
17. Takeda A, Homma S, Okamoto T et al. Immature dendritic cell/tumor cell fusions induce potent antitumour immunity. Eur. J. Clin. Invest. 2003 33 : 897 904.
18. Chakraborty M, Abrams SI, Camphausen K et al. Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. J. Immunol. 2003 170 : 6338 47.
19. Yang Q, Goding S, Hagenaars M et al. Morphological appearance, content of extracellular matrix and vascular density of lung metastases predicts permissiveness to infiltration by adoptively transferred natural killer and T cells. Cancer Immunol. Immunother. 2006 55 : 699 707.
20. Kuriyama S, Matsumoto M, Mitoro A et al. Electrochemotherapy for colorectal cancer with commonly used chemotherapeutic agents in a mouse model. Dig. Dis. Sci. 2000 45 : 1568 77.
21. Noy R, Ben-Zvi Z, Elezra M et al. Pharmacokinetics and organ distribution of N-methanocarbathymidine, a novel thymidine analog, in mice bearing tumors transduced with the herpes simplex thymidine kinase gene. Cancer Chemother. Pharmacol. 2002 50 : 360 6.
22. Eguchi J, Hiroishi K, Ishii S et al. Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-alpha transduction. Gene Ther. 2005 12 : 733 41.
23. Henry F, Bretaudeau L, Hequet A et al. Role of antigen-presenting cells in long-term antitumor response based on tumor-derived apoptotic body vaccination. Pathobiology 1999 67 : 306 10.
24. Williams CS, Tsujii M, Reese J et al. Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Invest. 2000 105 : 1589 94.
25. Mueller MM, Fusenig NE. Friends or foes: bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 2004 4 : 839 49.
26. Bhowmick NA, Moses HL. Tumor-stroma interactions. Curr. Opin. Genet Dev. 2005 15 : 97 101.
27. Yasumaru M, Tsuji S, Tsujii M et al. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway. Cancer Res. 2003 63 : 6726 34.
28. Ishii G, Sangai T, Oda T et al. Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem. Biophys. Res. Commun. 2003 309 : 232 40.
29. Direkze NC, Hodivala-Dilke K, Jeffery R et al. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 2004 64 : 8492 5.
30. Peters BA, Diaz LA, Polyak K et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat. Med. 2005 11 : 261 2.